UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549

NOTICE OF EFFECTIVENESS

Effective Date:December 18,
Aptevo Therapeutics (NASDAQ:APVO)
Historical Stock Chart
From Aug 2024 to Oct 2024 Click Here for more Aptevo Therapeutics Charts.
Aptevo Therapeutics (NASDAQ:APVO)
Historical Stock Chart
From Oct 2023 to Oct 2024 Click Here for more Aptevo Therapeutics Charts.

Aptevo Therapeutics Inc. News

Form PRE 14A - Other preliminary proxy statements
Tuesday 24 September 2024 (7 days ago) • Edgar (US Regulatory)
Form 8-K - Current report
Thursday 19 September 2024 (2 weeks ago) • Edgar (US Regulatory)
Form 424B4 - Prospectus [Rule 424(b)(4)]
Wednesday 18 September 2024 (2 weeks ago) • Edgar (US Regulatory)
Form EFFECT - Notice of Effectiveness
Tuesday 17 September 2024 (2 weeks ago) • Edgar (US Regulatory)
Form 8-K - Current report
Monday 16 September 2024 (2 weeks ago) • Edgar (US Regulatory)
Form S-1 - General form for registration of securities under the Securities Act of 1933
Saturday 31 August 2024 (1 month ago) • Edgar (US Regulatory)
Form 4 - Statement of changes in beneficial ownership of securities
Saturday 10 August 2024 (2 months ago) • Edgar (US Regulatory)
Form 4 - Statement of changes in beneficial ownership of securities
Saturday 10 August 2024 (2 months ago) • Edgar (US Regulatory)
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Thursday 8 August 2024 (2 months ago) • Edgar (US Regulatory)
Form 8-K - Current report
Thursday 8 August 2024 (2 months ago) • Edgar (US Regulatory)
Form 8-K - Current report
Thursday 8 August 2024 (2 months ago) • Edgar (US Regulatory)
Form 4 - Statement of changes in beneficial ownership of securities
Saturday 20 July 2024 (2 months ago) • Edgar (US Regulatory)

More Aptevo Therapeutics Inc. News Articles